rs117367857

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_015346.4(ZFYVE26):​c.2826G>A​(p.Met942Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0112 in 1,614,134 control chromosomes in the GnomAD database, including 154 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0081 ( 15 hom., cov: 33)
Exomes 𝑓: 0.012 ( 139 hom. )

Consequence

ZFYVE26
NM_015346.4 missense

Scores

16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -2.78

Publications

9 publications found
Variant links:
Genes affected
ZFYVE26 (HGNC:20761): (zinc finger FYVE-type containing 26) This gene encodes a protein which contains a FYVE zinc finger binding domain. The presence of this domain is thought to target these proteins to membrane lipids through interaction with phospholipids in the membrane. Mutations in this gene are associated with autosomal recessive spastic paraplegia-15. [provided by RefSeq, Oct 2008]
ZFYVE26 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 15
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Myriad Women’s Health, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0047784746).
BP6
Variant 14-67789528-C-T is Benign according to our data. Variant chr14-67789528-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 220334.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0081 (1234/152298) while in subpopulation NFE AF = 0.0128 (869/68024). AF 95% confidence interval is 0.0121. There are 15 homozygotes in GnomAd4. There are 557 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 15 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015346.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ZFYVE26
NM_015346.4
MANE Select
c.2826G>Ap.Met942Ile
missense
Exon 16 of 42NP_056161.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ZFYVE26
ENST00000347230.9
TSL:1 MANE Select
c.2826G>Ap.Met942Ile
missense
Exon 16 of 42ENSP00000251119.5
ZFYVE26
ENST00000555452.1
TSL:1
c.2826G>Ap.Met942Ile
missense
Exon 16 of 35ENSP00000450603.1
ZFYVE26
ENST00000554523.5
TSL:1
n.2963G>A
non_coding_transcript_exon
Exon 16 of 41

Frequencies

GnomAD3 genomes
AF:
0.00812
AC:
1235
AN:
152180
Hom.:
15
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00217
Gnomad AMI
AF:
0.0493
Gnomad AMR
AF:
0.00465
Gnomad ASJ
AF:
0.0306
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00331
Gnomad FIN
AF:
0.00198
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0128
Gnomad OTH
AF:
0.00670
GnomAD2 exomes
AF:
0.00834
AC:
2091
AN:
250810
AF XY:
0.00834
show subpopulations
Gnomad AFR exome
AF:
0.00235
Gnomad AMR exome
AF:
0.00408
Gnomad ASJ exome
AF:
0.0283
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00176
Gnomad NFE exome
AF:
0.0126
Gnomad OTH exome
AF:
0.00980
GnomAD4 exome
AF:
0.0115
AC:
16838
AN:
1461836
Hom.:
139
Cov.:
31
AF XY:
0.0112
AC XY:
8155
AN XY:
727216
show subpopulations
African (AFR)
AF:
0.00221
AC:
74
AN:
33480
American (AMR)
AF:
0.00407
AC:
182
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0300
AC:
785
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00322
AC:
278
AN:
86258
European-Finnish (FIN)
AF:
0.00204
AC:
109
AN:
53368
Middle Eastern (MID)
AF:
0.0107
AC:
62
AN:
5768
European-Non Finnish (NFE)
AF:
0.0132
AC:
14716
AN:
1112008
Other (OTH)
AF:
0.0105
AC:
632
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1049
2097
3146
4194
5243
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
576
1152
1728
2304
2880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00810
AC:
1234
AN:
152298
Hom.:
15
Cov.:
33
AF XY:
0.00748
AC XY:
557
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.00217
AC:
90
AN:
41556
American (AMR)
AF:
0.00464
AC:
71
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0306
AC:
106
AN:
3468
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5184
South Asian (SAS)
AF:
0.00311
AC:
15
AN:
4828
European-Finnish (FIN)
AF:
0.00198
AC:
21
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0128
AC:
869
AN:
68024
Other (OTH)
AF:
0.00663
AC:
14
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
58
116
175
233
291
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0112
Hom.:
31
Bravo
AF:
0.00786
TwinsUK
AF:
0.0135
AC:
50
ALSPAC
AF:
0.0130
AC:
50
ESP6500AA
AF:
0.00295
AC:
13
ESP6500EA
AF:
0.0145
AC:
125
ExAC
AF:
0.00806
AC:
979
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.0132
EpiControl
AF:
0.0122

ClinVar

ClinVar submissions as Germline

Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
3
not specified (3)
-
-
2
Hereditary spastic paraplegia 15 (2)
-
-
1
Hereditary spastic paraplegia (1)
-
-
1
Spastic paraplegia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.71
T
BayesDel_noAF
Benign
-0.78
CADD
Benign
0.0010
DANN
Benign
0.81
DEOGEN2
Benign
0.0028
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.030
N
LIST_S2
Benign
0.28
T
MetaRNN
Benign
0.0048
T
MetaSVM
Benign
-1.0
T
PhyloP100
-2.8
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.080
N
REVEL
Benign
0.044
Sift
Benign
0.25
T
Sift4G
Benign
0.39
T
Polyphen
0.0
B
Vest4
0.19
MutPred
0.24
Loss of disorder (P = 0.1701)
MVP
0.099
MPC
0.18
ClinPred
0.0067
T
GERP RS
-11
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.35
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117367857; hg19: chr14-68256245; COSMIC: COSV99052073; API